Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,902.50    -1.00 (-0.05%)
Bid:
1,902.00
Ask:
1,903.00
Spread: 1.00 (0.053%)
Market Cap: £76.27b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

LONDON BRIEFING: FTSE called down amid political uncertainty in EU
10 Jun 2024

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's lat...

GSK's Arexvy vaccine approved for wider age range
10 Jun 2024

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

What to know about bird flu in dairy cows and the risk to humans
7 Jun 2024

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total numbe...

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'
5 Jun 2024

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

European shares kick-off June on a high note in anticipation of ECB rate cut
3 Jun 2024

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed *

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York
3 Jun 2024

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

GSK immunotherapy bowel cancer drug works for 100% of patients
3 Jun 2024

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective ...